A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment.

Renal impairment (RI) is known to influence the pharmacokinetics of nonrenally eliminated drugs, although the mechanism and clinical impact is poorly understood. We assessed the impact of RI and single dose oral rifampin (RIF) on the pharmacokinetics of CYP3A, OATP1B, P-gp, and BCRP substrates using a microdose cocktail and OATP1B endogenous biomarkers. RI alone had no impact on midazolam (MDZ), maximum plasma concentration (Cmax ), and area under the curve (AUC), but a progressive increase in AUC with RI severity for dabigatran (DABI), and up to ~2-fold higher AUC for pitavastatin (PTV), rosuvastatin (RSV), and atorvastatin (ATV) for all degrees of RI was observed. RIF did not impact MDZ, had a progressively smaller DABI drug-drug interaction (DDI) with increasing RI severity, a similar 3.1-fold to 4.4-fold increase in PTV and RSV AUC in healthy volunteers and patients with RI, and a diminishing DDI with RI severity from 6.1-fold to 4.7-fold for ATV. Endogenous biomarkers of OATP1B (bilirubin, coproporphyrin I/III, and sulfated bile salts) were generally not impacted by RI, and RIF effects on these biomarkers in RI were comparable or larger than those in healthy volunteers. The lack of a trend with RI severity of PTV and several OATP1B biomarkers, suggests that mechanisms beyond RI directly impacting OATP1B activity could also be considered. The DABI, RSV, and ATV data suggest an impact of RI on intestinal P-gp, and potentially BCRP activity. Therefore, DDI data from healthy volunteers may represent a worst-case scenario for clinically derisking P-gp and BCRP substrates in the setting of RI.

Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection.

The RSV Fusion (F) protein is a target for neutralizing antibody responses and is a focus for vaccine discovery; however, the process of RSV entry requires F to adopt a metastable prefusion form and transition to a more stable postfusion form, which displays less potent neutralizing epitopes. mRNA vaccines encode antigens that are translated by host cells following vaccination, which may allow conformational transitions similar to those observed during natural infection to occur. Here we evaluate a panel of chemically modified mRNA vaccines expressing different forms of the RSV F protein, including secreted, membrane associated, prefusion-stabilized, and non-stabilized structures, for conformation, immunogenicity, protection, and safety in rodent models. Vaccination with mRNA encoding native RSV F elicited antibody responses to both prefusion- and postfusion-specific epitopes, suggesting that this antigen may adopt both conformations in vivo. Incorporating prefusion stabilizing mutations further shifts the immune response toward prefusion-specific epitopes, but does not impact neutralizing antibody titer. mRNA vaccine candidates expressing either prefusion stabilized or native forms of RSV F protein elicit robust neutralizing antibody responses in both mice and cotton rats, similar to levels observed with a comparable dose of adjuvanted prefusion stabilized RSV F protein. In contrast to the protein subunit vaccine, mRNA-based vaccines elicited robust CD4+ and CD8+ T-cell responses in mice, highlighting a potential advantage of the technology for vaccines requiring a cellular immune response for efficacy.

Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugates.

The greatest challenge standing in the way of effective in vivo siRNA delivery is creating a delivery vehicle that mediates a high degree of efficacy with a broad therapeutic window. Key structure-activity relationships of a poly(amide) polymer conjugate siRNA delivery platform were explored to discover the optimized polymer parameters that yield the highest activity of mRNA knockdown in the liver. At the same time, the poly(amide) backbone of the polymers allowed for the metabolism and clearance of the polymer from the body very quickly, which was established using radiolabeled polymers to demonstrate the time course of biodistribution and excretion from the body. The fast degradation and clearance of the polymers provided for very low toxicity at efficacious doses, and the therapeutic window of this poly(amide)-based siRNA delivery platform was shown to be much broader than a comparable polymer platform. The results of this work illustrate that the poly(amide) platform has a promising future in the development of a siRNA-based drug approved for human use.

An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agents.

A series of amphiphilic, biodegradable polypeptide copolymers were prepared for the delivery of siRNA (short interfering ribonucleic acid). The molecular weight (or polymer chain length) of the linear polymer was controlled by reaction stoichiometry for the 11.5, 17.2, and 24.6 kDa polypeptides, and the highest molecular weight polypeptide was prepared using a sequential addition method to obtain a polypeptide having a molecular weight of 38.6 kDa. These polymers were used to prepare polymer conjugate systems designed to target and deliver an apolipoprotein B (ApoB) siRNA to hepatocyte cells and to help delineate the effect of polymer molecular weight or polymer chain length on siRNA delivery in vivo. A clear trend in increasing potency was found with increasing molecular weight of the polymers examined (at a constant polymer:siRNA (w/w) ratio), with minimal toxicity found. Furthermore, the biodegradability of these polymer conjugates was examined and demonstrates the potential of these systems as siRNA delivery vectors.

Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsiveness.

Polymer based carriers that aid in endosomal escape have proven to be efficacious siRNA delivery agents in vitro and in vivo; however, most suffer from cytotoxicity due in part to a lack of selectivity for endosomal versus cell membrane lysis. For polymer based carriers to move beyond the laboratory and into the clinic, it is critical to find carriers that are not only efficacious, but also have margins that are clinically relevant. In this paper we report three distinct categories of polymer conjugates that improve the selectivity of endosomal membrane lysis by relying on the change in pH associated with endosomal trafficking, including incorporation of low pKa heterocycles, acid cleavable amino side chains, or carboxylic acid pH sensitive charge switches. Additionally, we determine the therapeutic index of our polymer conjugates in vivo and demonstrate that the incorporation of pH responsive elements dramatically expands the therapeutic index to 10-15, beyond that of the therapeutic index (less than 3), for polymer conjugates previously reported.

Diffusive flux and magnetic manipulation of nanoparticles through porous membranes.

Measurement of transport of nanometer scale particles through porous media is important to begin to understand the potential environmental impacts of nanomaterials. Using a diffusion cell with two compartments separated by either a porous alumina or polycarbonate membrane as a model system, diffusive flux through mesoporous materials is examined. Experiments are performed as a function of particle size, pore diameter, and solvent, and the particle fluxes are monitored by the change in absorbance of the solution in the receiving cell. Using the measured extinction coefficient and change in absorbance of the solution as a function of time, the fluxes of 3, 8, and 14 nm diameter CoFe(2)O(4) particles are determined as they are translocated across pores with diameters 30, 50, 100, and 200 nm in hexane and aqueous solutions. In general, flux decreases with increasing particle size and increases with pore diameter. We find that fluxes are faster in aqueous solutions than in hexane, which is attributed to the hydrophilic nature of the porous membranes and differences in wettability. The impact of an applied magnetic flux gradient, which induces magnetization and motion, on permeation is also examined. For larger membrane pore diameters, applied magnetic fluxes increase the rate of transport of 14 nm CoFe(2)O(4) particles more than that of 3 or 8 nm diameter particles, reflecting their differences in susceptibility. However, larger particles are excluded from membranes with small diameter pores, consistent with magnetic interparticle attractions that reversibly induce magnetic aggregation.

Differential magnetic catch and release: analysis and separation of magnetic nanoparticles.

This article reports the purification and separation of magnetic nanoparticle mixtures using differential magnetic catch and release (DMCR). This method applies a variable magnetic flux orthogonal to the flow direction in an open tubular capillary to trap and controllably release magnetic nanoparticles. Magnetic moments of 8, 12, and 17 nm diameter CoFe2O4 nanoparticles are calculated using the applied magnetic flux and experimentally determined force required to trap 50% of the particle sample. Balancing the relative strengths of the drag and magnetic forces enables separation and purification of magnetic CoFe2O4 nanoparticle samples with <20 nm diameters. Samples were characterized by transmission electron microscopy to determine the average size and size dispersity of the sample population. DMCR is further demonstrated to be useful for separation of a magnetic nanoparticle mixture, resulting in samples with narrowed size distributions.

Controlling transport and chemical functionality of magnetic nanoparticles.

A wide range of metal, magnetic, semiconductor, and polymer nanoparticles with tunable sizes and properties can be synthesized by wet-chemical techniques. Magnetic nanoparticles are particularly attractive because their inherent superparamagnetic properties make them desirable for medical imaging, magnetic field assisted transport, and separations and analyses. With such applications on the horizon, synthetic routes for quickly and reliably rendering magnetic nanoparticle surfaces chemically functional have become an increasingly important focus. This Account describes common synthetic routes for making and functionalizing magnetic nanoparticles and discusses initial applications in magnetic field induced separations. The most widely studied magnetic nanoparticles are iron oxide (Fe2O3 and Fe3O4), cobalt ferrite (CoFe 2O4), iron platinum (FePt), and manganese ferrite (MnFe 2O4), although others have been investigated. Magnetic nanoparticles are typically prepared under either high-temperature organic phase or aqueous conditions, producing particles with surfaces that are stabilized by attached surfactants or associated ions. Although it requires more specialized glassware, high-temperature routes are generally preferred when a high degree of stability and low particle size dispersity is desired. Particles can be further modified with a secondary metal or polymer to create core-shell structures. The outer shells function as protective layers for the inner metal cores and alter the surface chemistry to enable postsynthetic modification of the surfactant chemistry. Efforts by our group as well as others have centered on pathways to yield nanoparticles with surfaces that are both easily functionalized and tunable in terms of the number and variety of attached species. Ligand place-exchange reactions have been shown quite successful for exchanging silanes, acids, thiols, and dopamine ligands onto the surfaces of some magnetic particles. Poly(ethylene oxide)-modified phospholipids can be inserted into nonpolar surface monolayers of as-prepared nanoparticles as a method for modifying the surface chemistry that induces water solubility. In general, reactive termini can subsequently be used to append a range of chemical groups. For example, surfactants with trifluoroethylester or azide termini have been used to attach a range of amine- or alkyne-containing species, respectively. Chemically functionalized magnetic nanoparticles are promising as advanced materials for analytical separations and analysis. Magnetic field flow fractionation leverages the size-dependent magnetic moments to purify and separate the components of a complex mixture of particles. Similarly, magnetic field gradients are useful for manipulating transport and separation in simple microfluidic devices. By either approach, magnet-induced transport of the particles is a simple method in which an attached reagent, catalyst, or bioanalytical tag can be moved between flow streams within a lab on a chip device.

Transmission electron microscope-induced structural evolution in amorphous Fe, Co, and Ni oxide nanoparticles.

The high-energy electron beams in transmission electron microscopes (TEM) are known to cause structural changes and damage in some materials. In this paper, we describe unique and reproducible TEM-induced changes to the morphology of amorphous metal oxide (Fe, Co, and Ni) nanoparticles. The studied particles were synthesized via literature methods and fully characterized by X-ray powder diffraction and time-resolved, low-dose TEM. As a result of electron beam irradiation, we observe these particles to transform from initially solid spheres to core/void/shell structures and eventually to hollow nanoparticles. The rate of these transformations depends on the size and composition of the particles but is not unique to the Fe oxide we previously reported. These data suggest that structural analysis of nanoparticles by TEM must consider the impact of the high-energy electron beam and use low-dose imaging.

Magnetic field switching of nanoparticles between orthogonal microfluidic channels.

This paper reports on the manipulation of magnetic nanoparticles between microfluidic channels by the application of an external magnet. Two orthogonal channels were prepared using standard PDMS techniques with pressure-driven flow used to deliver the mobile phase. To study the ability to control magnetic nanoparticles within micrometer-sized channels, Fe2O3, MnFe2O4, and Au nanoparticle samples were compared. For the magnetic particles, transfer between flow streams is greatly increased by placing a permanent magnet beneath the intersection of the channels, but no change is observed for the nonmagnetic Au particles. More nanoparticles are magnetically transferred into the orthogonal channel as the solvent flow rate decreases. We demonstrate the ability to use this technique to perform multiple injections of plugs of magnetic particles by periodic application of a magnetic field.

TEM-induced structural evolution in amorphous Fe oxide nanoparticles.

Exposure to the high energy electron beam of a TEM changes the morphology of amorphous Fe oxide nanoparticles from solid spheres to hollow shells. Amorphous Fe oxide nanoparticles prepared via high-temperature methods using hexadecylamine and trioctylphosphine oxide surfactants were compared to crystalline gamma-Fe2O3 particles of similar size. Both sets of particles are fully characterized via SQUID magnetometry, X-ray powder diffraction, BET surface analysis, EPR spectroscopy, high-resolution transmission electron microscopy (TEM), and electron energy loss spectroscopy (EELS). Time-resolved TEM images reveal that the amorphous Fe oxide particles evolve from solid spheres into hollow shells in <2 min, whereas crystalline gamma-Fe2O3 are unaffected by the electron beam. The resulting nanocrystalline Fe oxide shells bear striking resemblance to core-shell nanocrystals, but are a result of a morphology change attributed to restructuring of particle voids and defects induced by quasi-melting in the TEM. These results thus imply that caution is necessary when using TEM to analyze nanoparticle core-shell and heterostructured nanoparticles.

Versatile routes toward functional, water-soluble nanoparticles via trifluoroethylester-PEG-thiol ligands.

This paper reports the synthesis of a trifluoroethylester-PEG-thiol ligand (TFEE-PEG-SH) and its use to create water-soluble, chemically functional Au metal and FePt magnetic nanoparticles. The trifluoroethylester terminus facilitates attachment of any primary-amine-containing molecule via amide bond formation at room temperature without the use of coupling agents. Three possible routes of nanoparticle functionalization are demonstrated: synthesis of Au nanoparticles in the presence of functionalized R-PEG-SH; ligand-exchange of R-PEG-SH onto both Au and FePt nanoparticles; and exchange of TFEE-PEG-SH onto Au nanoparticles followed by subsequent amide condensation. A series of primary-amine-containing molecules, including biotin and fluorescamine, are easily attached to the water-soluble particles, and the resulting materials are characterized by NMR, UV-visible absorption, and emission spectroscopies.

Capillary magnetic field flow fractionation and analysis of magnetic nanoparticles.

This paper reports the purification and analysis of magnetic nanoparticles using capillary magnetic field flow fractionation, which utilizes an applied magnetic field oriented orthogonal to the capillary flow. To validate this approach as a separation method for nanometer-scale particles, samples of magnetic nanoparticles composed of either gamma-Fe2O3 (maghemite) or CoFe2O4 with average diameters ranging from 4 to 13 nm were prepared and characterized by transmission electron microscopy and SQUID magnetometry. Retention of the samples on the capillary was investigated as a function of solvent flow rate and the nanoparticle size and composition; the elution times of the nanoparticles are strongly dependent on their magnetic moments. We demonstrate the use of this method to separate a mixture of nanoparticles into size-monodisperse fractions. The magnetic moments of the particles are calculated based on analysis of the retention parameters and correlate with values obtained in separate SQUID magnetometry measurements.